Загрузка...
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy with an overall 5-year survival rate of 10%. Disease lethality is due to late diagnosis, early metastasis and resistance to therapy, including immunotherapy. PDA creates a robust fibroinflammatory tumor microenvironment that contributes t...
Сохранить в:
| Опубликовано в: : | Front Immunol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7876239/ https://ncbi.nlm.nih.gov/pubmed/33584701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.613815 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|